Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

July 31, 2005

Conditions

Human Experimentation (Human Volunteers)

Interventions

DRUG

Rupatadine

DRUG

moxifloxacin

PROCEDURE

Continous electrocardiographic register

PROCEDURE

Pharmacokinetic profile

Trial Locations (1)

Centre de Investigació de Medicaments-Intitut de Recerca-Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors

lead

J. Uriach and Company

INDUSTRY

NCT00199225 - Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers | Biotech Hunter | Biotech Hunter